Mapping genetic contributions to cardiac pathology induced by beta-adrenergic stimulation in mice

Circulation: Cardiovascular Genetics

Volumn 8, Issue 1, 2015, Pages 40-49

  Rau, Christoph D ^a   Wang, Jessica ^a   Avetisyan, Rozeta ^a   Romay, Milagros C ^a   Martin, Lisa ^a   Ren, Shuxun ^a   Wang, Yibin ^a   Lusis, Aldons J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catecholamine; Genome wide association scan; Genomics; Heart failure; Mouse

Indexed keywords

ISOPRENALINE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 6; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HEART DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CARDIOMEGALY; CHEMICALLY INDUCED; CHROMOSOME MAP; FEMALE; FIBROSIS; GENETICS; HUMAN; PATHOLOGY;

MUS;

ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIOMEGALY; CHROMOSOME MAPPING; FEMALE; FIBROSIS; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ISOPROTERENOL; MICE;

EID: 84924576455     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000732     Document Type: Article

References (40)

1. Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature. 2008;451:919-928. doi: 10.1038/nature06798.
2. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89:151-163.
3. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159-173. doi: 10.1161/CIRCRESAHA. 111.243162.
4. Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71:549-574. doi: 10.1007/s00018-013-1349-6.
5. Villard E, Perret C, Gary F, Proust C, Dilanian G, Hengstenberg C, et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J. 2011;32:1065-1076.
6. Morrison AC, Felix JF, Cupples LA, Glazer NL, Loehr LR, Dehghan A, et al. Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circ Cardiovasc Genet. 2010;3:248-255. doi: 10.1161/CIRCGENETICS.109.895995.
7. Parsa A, Chang YP, Kelly RJ, Corretti MC, Ryan KA, Robinson SW, et al. Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin Transl Sci. 2011;4:17-23. doi: 10.1111/j.1752-8062.2010.00251.x.
8. Le Corvoisier P, Park HY, Carlson KM, Marchuk DA, Rockman HA. Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathy. Hum Mol Genet. 2003;12:3097-3107. doi: 10.1093/hmg/ddg333.
9. McDermott-Roe C, Ye J, Ahmed R, Sun XM, Serafín A, Ware J, et al. Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature. 2011;478:114-118. doi: 10.1038/nature10490.
10. Wheeler FC, Fernandez L, Carlson KM, Wolf MJ, Rockman HA, Marchuk DA. QTL mapping in a mouse model of cardiomyopathy reveals an ancestral modifier allele affecting heart function and survival. Mamm Genome. 2005;16:414-423. doi: 10.1007/s00335-005-2468-7.
11. Wheeler FC, Tang H, Marks OA, Hadnott TN, Chu PL, Mao L, et al. Tn-ni3k modifies disease progression in murine models of cardiomyopathy. PLoS Genet. 2009;5:e1000647. doi: 10.1371/journal.pgen.1000647.
12. Bennett BJ, Farber CR, Orozco L, Kang HM, Ghazalpour A, Siemers N, et al. A high-resolution association mapping panel for the dissection of complex traits in mice. Genome Res. 2010;20:281-290. doi: 10.1101/gr.099234.109.
13. Mungrue IN, Zhao P, Yao Y, Meng H, Rau C, Havel JV, et al. Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model. Arterioscler Thromb Vasc Biol. 2011;31:2806-2812. doi: 10.1161/ATVBAHA.111.237420.
14. Martin LJ, Lau E, Singh H, Vergnes L, Tarling EJ, Mehrabian M, et al. ABCC6 localizes to the mitochondria-associated membrane. Circ Res. 2012;111:516-520. doi: 10.1161/CIRCRESAHA.112.276667.
15. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest. 2007;117:568-575. doi: 10.1172/JCI31044.
16. Bronson RT. Rate of occurrence of lesions in 20 inbred and hybrid genotypes of rats and mice sacrificed at 6-month intervals during the first years of life. In: Harrison D, ed. Genetic Effects of Aging II. Caldwell, NJ: Telford Press; 1990:279-358.
17. Kang HM, Zaitlen NA, Wade CM, Kirby A, Heckerman D, Daly MJ, et al. Efficient control of population structure in model organism association mapping. Genetics. 2008;178:1709-1723. doi: 10.1534/genetics.107.080101.
18. Smyth GK. No Title. In: Gentleman R, Irizarry W, Huber W, ed. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York: Springer; 2005:397-420.
19. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118-127. doi: 10.1093/biostatistics/kxj037.
20. Parks BW, Nam E, Org E, Kostem E, Norheim F, Hui ST, et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 2013;17:141-152. doi: 10.1016/j.cmet.2012.12.007.
21. Grundberg E, Small KS, Hedman ÅK, Nica AC, Buil A, Keildson S, et al.; Multiple Tissue Human Expression Resource (MuTHER) Consortium. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet. 2012;44:1084-1089. doi: 10.1038/ng.2394.
22. Borel C, Deutsch S, Letourneau A, Migliavacca E, Montgomery SB, Dimas AS, et al. Identification of cis- and trans-regulatory variation modulating microRNA expression levels in human fibroblasts. Genome Res. 2011;21:68-73. doi: 10.1101/gr.109371.110.
23. Nica AC, Ongen H, Irminger JC, Bosco D, Berney T, Antonarakis SE, et al. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res. 2013;23:1554-1562. doi: 10.1101/gr.150706.112.
24. Hasin-Brumshtein Y, Hormozdiari F, Martin L, van Nas A, Eskin E, Lusis AJ, et al. Allele-specific expression and eQTL analysis in mouse adipose tissue. BMC Genomics. 2014;15:471. doi: 10.1186/1471-2164-15-471.
25. Dorn GW III, Liggett SB. Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure. Clin Transl Sci. 2008;1:255-262. doi: 10.1111/j.1752-8062.2008.00059.x.
26. Breckenridge R. Heart failure and mouse models. Dis Model Mech. 2010;3:138-143. doi: 10.1242/dmm.005017.
27. Zhang X, Szeto C, Gao E, Tang M, Jin J, Fu Q, et al. Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling. Circ Res. 2013;112:498-509. doi: 10.1161/CIRCRESAHA.112.273896.
28. Berthonneche C, Peter B, Schüpfer F, Hayoz P, Kutalik Z, Abriel H, et al. Cardiovascular response to beta-adrenergic blockade or activation in 23 inbred mouse strains. PLoS One. 2009;4:e6610. doi: 10.1371/journal.pone.0006610.
29. Flint J, Eskin E. Genome-wide association studies in mice. Nat Rev Genet. 2012;13:807-817. doi: 10.1038/nrg3335.
30. Yalcin B, Wong K, Agam A, Goodson M, Keane TM, Gan X, et al. Sequence-based characterization of structural variation in the mouse genome. Nature. 2011;477:326-329. doi: 10.1038/nature10432.
31. Schönberger J, Seidman CE. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet. 2001;69:249-260. doi: 10.1086/321978.
32. Bauer R, Macgowan GA, Blain A, Bushby K, Straub V. Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycandeficient mouse model for dilated cardiomyopathy. Cardiovasc Res. 2008;79:652-661. doi: 10.1093/cvr/cvn131.
33. Banerjee SK, McGaffin KR, Huang XN, Ahmad F. Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation. Biochim Biophys Acta. 2010;1802:284-291. doi: 10.1016/j.bbadis.2009.12.001.
34. Pall GS, Wallis J, Axton R, Brownstein DG, Gautier P, Buerger K, et al. A novel transmembrane MSP-containing protein that plays a role in right ventricle development. Genomics. 2004;84:1051-1059. doi: 10.1016/j.ygeno.2004.08.017.
35. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3.
36. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44-57. doi: 10.1038/nprot.2008.211.
37. Ellinor PT, Sasse-Klaassen S, Probst S, Gerull B, Shin JT, Toeppel A, et al. A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26. J Am Coll Cardiol. 2006;48:106-111. doi: 10.1016/j.jacc.2006.01.079.
38. Meng H, Vera I, Che N, Wang X, Wang SS, Ingram-Drake L, et al. Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci U S A. 2007;104:4530-4535. doi: 10.1073/pnas.0607620104.
39. Campens L, Vanakker OM, Trachet B, Segers P, Leroy BP, De Zaeytijd J, et al. Characterization of cardiovascular involvement in pseudoxanthoma elasticum families. Arterioscler Thromb Vasc Biol. 2013;33:2646-2652. doi: 10.1161/ATVBAHA.113.301901.
40. Jiang Q, Oldenburg R, Otsuru S, Grand-Pierre AE, Horwitz EM, Uitto J. Parabiotic heterogenetic pairing of Abcc6-/-/Rag1-/- mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum. Am J Pathol. 2010;176:1855-1862. doi: 10.2353/ajpath.2010.090983.